Kozmin produced an adverse analytical finding for the banned hormone and metabolic modulator during the 2016 World Open in Dubai.

"As a result of his violation, Kozmin was ruled ineligible from competition from 23 May 2016 until 23 May 2017," a statement posted on the website of the Boccia International Sports Federation (BISFed) announced.

"All Kozmin’s results obtained during the 2016 World Open in Dubai and onwards until 23 May 2017 will be disqualified including forfeiture of any medals and points.2

It is not yet clear, however, whether Kozmin remains suspended from competition or whether the whole Russian team will be disqualified from every event he featured in.

Kozmin finished fourth in the BC 1/2 team event before also finishing in the same position in the BC 2 individual category.

insidethegames has contacted BISFed for further clarification.

Russia remains suspended from competing at the Paralympics by the International Paralympic Committee following the McLaren Report evidence into doping there.

Trimetazidenea is a drug used to treat angina pectoris.

"The principle of strict liability applies to anti-doping matters," said BISFed in their statement.

"Therefore, each athlete is strictly liable for the substances found in his or her sample, and an anti-doping rule violation occurs whenever a prohibited substance (or its metabolites or markers) is found in his or her bodily specimen, whether or not the athlete intentionally or unintentionally used a prohibited substance or was negligent or otherwise at fault."